心肺氧合器市场基于(主要地区、市场参与者、规模和份额)- 预测至 2028 年

  • Report Code : TIPRE00029843
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 236
Buy Now

Cardiopulmonary Oxygenator Market Size & Share Statistics 2028

Buy Now

 

[研究报告] 全球心肺氧合器市场预计将从 2022 年的 7.1621 亿美元增长到 2028 年的 9.0415 亿美元;预计2022 年至 2028 年的复合年增长率为 4.0%。

2022 年,北美占据了主要市场份额,美国是该地区市场的最大贡献者。市场增长归因于心血管和呼吸系统疾病患病率的上升,这增加了COPD、慢性支气管炎和充血性心力衰竭等心肺疾病的发病率。例如,根据美国肺脏协会的数据,2020 年美国约有 1250 万人被诊断出患有COPD、慢性支气管炎和肺气肿。此外,此类疾病患病率和发病率的上升增加了大量患者群体中的外科手术数量,从而推动了心肺氧合器市场的增长。例如,根据生命周期健康系统发布的一项研究,美国每年进行约 500,00 次心脏直视手术。此外,呼吸衰竭和传染病患病率的增加预计将在未来几年 进一步创造对心肺氧合器的需求。

此外,心血管疾病的患病率不断上升,是全球范围内死亡的主要原因,而氧合器在救生紧急情况下可以提供很大的帮助。根据世界卫生组织的数据,每年约有 1790 万人死于心血管疾病。此外,有利的报销政策也有望为未来几年心肺氧合器市场的增长创造充足的机会。因此,预计心肺疾病患病率和发病率的上升将在预测期内推动心肺氧合器市场的增长。

 

心肺氧合器市场 -

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

心肺氧合器市场:

心肺氧合器市场

  • 复合年增长率(2022 - 2028)
    4.0%
  • 2022 年市场规模
    7.1621 亿美元
  • 2028 年市场规模
    9.0415 亿美元

市场动态

增长动力
  • 財政部
  • 財政部
  • 財政部
未来的趋势
  • 財政部
  • 財政部
  • 財政部
机会
  • 財政部
  • 財政部
  • 財政部

关键人物;主力;重要一员

  •  
  • 洁定公司
  • 利瓦诺瓦股份有限公司
  • 美敦力公司
  • 泰尔茂公司
  • 欧罗塞斯公司
  • 尼普洛医疗公司
  • 费森尤斯医药股份公司
  • 微创医疗科学公司
  • Braile Biomédica 工业、商业和代表有限公司

区域概况

  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

产品
  • 气泡氧合器和膜氧合器
应用
  • 心脏和呼吸系统
类型
  • 一次性心肺氧合器和重复使用心肺氧合器
年龄阶层
  • 成年人
  • 儿科
  • 新生儿
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

便携式 ECMO 设备的使用加速心肺氧合市场的增长。

60 多年来,第一款ECMO技术问世。第一款上市的型号体积庞大,形状怪异。随着便携式 ECMO 系统的推出,医生在治疗患有慢性 COPD 或心力衰竭的患者时可以安心了。这种新型便携式技术因其紧凑的尺寸而具有革命性;它也是左心室辅助装置 (LVAD) 治疗或肺移植的理想选择。便携式机器让医生有足够的时间了解患者的器官情况。小型便携式机器对接受一次以上器官移植的患者大有裨益。因此,便携式 ECMO 机器正在成为心肺氧合器市场的未来趋势。一些 ECMO 系统用于院内转运,而一些用于院间患者转运。新型 Capiox NX19 氧合器通过减少血液稀释、最大限度地减少炎症反应和帮助高效去除气体微栓子 (GME),帮助最大限度地减少心肺旁路的影响。

 

市场洞察 – 心肺氧合器市场

根据地区,心肺氧合器市场细分为北美、欧洲、亚太地区、南美和中东及非洲。2022 年,北美占据了心肺氧合器市场份额的主导地位。该地区的市场进一步细分为美国、加拿大和墨西哥。北美心肺氧合器市场的增长归因于该地区心血管和呼吸系统疾病患病率的上升。这增加了 COPD、慢性支气管炎和充血性心力衰竭等心肺疾病的发病率。例如,根据美国肺脏协会的数据,2020 年美国约有 1250 万人被诊断出患有 COPD、慢性支气管炎和肺气肿。因此,预计心肺疾病患病率和发病率的上升将在预测期内推动心肺氧合器市场的增长。

 

基于产品的洞察

根据产品,心肺氧合器市场分为膜氧合器和气泡氧合器。膜氧合器部分在 2022 年占据了更大的市场份额,预计在预测期内(2022-2028 年)的复合年增长率会更高。技术先进的膜氧合器预计将在预测期内推动心肺氧合器市场的增长。

心肺氧合器市场根据产品、应用、类型、年龄组和最终用途进行细分。根据产品,心肺氧合器市场分为气泡氧合器和膜氧合器。在应用方面,心肺氧合器市场分为心脏和呼吸系统。根据类型,市场分为一次性心肺氧合器和可重复使用心肺氧合器。根据年龄组,心肺氧合器市场分为成人、儿科和新生儿。根据最终用途,心肺氧合器市场分为医院和诊所、门诊手术中心和其他。根据地理位置,心肺氧合器市场主要分为北美、欧洲、亚太地区 (APAC)、中东和非洲 (MEA) 和南美 (SAM)。

 

心肺氧合器市场报告范围

报告属性细节
2022 年市场规模7.1621亿美元
2028 年市场规模9.0415亿美元
全球复合年增长率(2022 - 2028)4.0%
历史数据2020-2021
预测期2023-2028
涵盖的领域按产品
  • 气泡氧合器和膜氧合器
按应用
  • 心脏和呼吸系统
按类型
  • 一次性心肺氧合器和重复使用心肺氧合器
按年龄组
  • 成年人
  • 儿科
  • 新生儿
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • 洁定公司
  • 利瓦诺瓦股份有限公司
  • 美敦力公司
  • 泰尔茂公司
  • 欧罗塞斯公司
  • 尼普洛医疗公司
  • 费森尤斯医药股份公司
  • 微创医疗科学公司
  • Braile Biomédica 工业、商业和代表有限公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

心肺氧合器市场的主要市场参与者包括 Getinge AB、LivaNova Plc、Medtronic Plc、Terumo Corp、Eurosets SRL、Nipro Medical Corp、Fresenius Medical Care AG & Co. KGaA、MicroPort Scientific Corp、Braile Biomédica Industry, Commerce and Representations Ltd 和 Chalice Medical Ltd。

心肺氧合器市场参与者主要注重产品认可和公司扩张以创造客户价值。

  • 2022 年 11 月,LivaNova PLC 宣布其下一代高级循环支持 (ACS) 泵和控制器系统 LifeSPARC 已获得美国食品药品监督管理局 (FDA) 颁发的体外膜氧合 (ECMO) 510(k) 许可。
  • 2022 年 2 月,费森尤斯医疗宣布,美国食品药品监督管理局 (FDA) 已批准 Novalung,这是一种用于治疗急性呼吸或心肺衰竭的心肺支持系统。Novalung 是首个获准用于体外生命支持且使用时间超过六小时的体外膜氧合 (ECMO) 系统。
  • 2020年12月,Nipro Medical Corp宣布其合并子公司Nipro Australia PTY LTD已在澳大利亚维多利亚州墨尔本设立了销售办事处。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the key players in the cardiopulmonary oxygenator market?

Companies operating in the market are Getinge AB, LivaNova Plc, Medtronic Plc, Terumo Corp, Eurosets SRL, Nipro Medical Corp, Fresenius Medical Care AG & Co. KGaA, MicroPort Scientific Corp, Braile Biomédica Industry, Commerce and Representations Ltd, and Chalice Medical Ltd.

What is the regional market scenario of the cardiopulmonary oxygenator market?

Global home infusion therapy market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is likely to continue its dominance in the home infusion therapy market during 2022–2028. The US holds the largest share of the market in North America and is expected to continue this trend during the forecast period.

Which application segment held the largest revenue (US$ Mn) in the cardiopulmonary oxygenator market?

The cardiopulmonary oxygenators market, by application, is bifurcated into cardiac and respiratory. The cardiac segment held a larger market share in 2021 and is anticipated to register a higher CAGR during the forecast period (2022–2028).

What are the driving factors for the cardiopulmonary oxygenator market across the globe?

Key factors driving the market growth are rising incidences of cardiopulmonary diseases and increasing surgical procedures with surging in aging population.

Which product segment led cardiopulmonary oxygenator market?

The cardiopulmonary oxygenators market, by product, is bifurcated into membrane oxygenator and bubble oxygenator. The membrane oxygenator segment held a larger market share in 2021 and is anticipated to register a higher CAGR during the forecast period (2022–2028).

What is meant by the cardiopulmonary oxygenator market?

The oxygenator removes carbon dioxide and adds oxygen to the blood that is pumped into the arterial system. The blood pumped back into the patient’s arteries is sufficient to maintain life at even the most distant parts of the body as well as in the organs. Cardiopulmonary bypass (CPB) procedures require a blood-gas exchanger (oxygenator) to replace the respiratory function of the lungs temporarily. In the past the majority of CPB procedures have been carried out with bubble oxygenators which effect gas exchange by dispersion of bubbles into the blood. Membrane oxygenators, on the other hand, utilize a hydrophobic gas permeable membrane between the blood and gas phases. Bubble oxygenators are being superseded by membrane types for CPB due to improvements in membrane technology and mass transfer efficiency.

The List of Companies - Cardiopulmonary Oxygenator Market

  1. Getinge AB
  2. LivaNova Plc
  3. Medtronic Plc
  4. Terumo Corp
  5. Eurosets SRL
  6. Nipro Medical Corp
  7. Fresenius Medical Care AG & Co. KGaA
  8. MicroPort Scientific Corp
  9. Braile Biomédica Industry, Commerce and Representations Ltd
  10. Chalice Medical Ltd.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports